NovaBay receives superior offer from Refresh Acquisitions for Avenova at $11.5M

Stablecoin Development Corp

Refresh offers $11.5M base purchase price for Avenova assets, vs $9.5M from PRN.
Refresh provides $2M secured term loan at 10% interest, expected to be repaid at closing.
Board determined Refresh offer is a Superior Proposal; PRN has until Nov 4, 2024 to counter.
PRN deal remains in effect; board has not withdrawn recommendation pending PRN's response.
Refresh affiliate RVL Pharmaceuticals markets Upneeq; complements Avenova products.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.